'MDMA Therapy Gets Support From Prominent Research Group As FDA Weighs Action' - Green Market Report
Portfolio Pulse from Benzinga Newsdesk
A coalition of prominent researchers has urged the FDA to approve MDMA-based therapy for PTSD, highlighting its proven safety and efficacy. This comes as the FDA is set to rule on Lykos Therapeutics' MDMA therapy by August 11. The paper emphasizes the urgent need for effective PTSD treatments, citing high suicide rates among U.S. military veterans.
July 16, 2024 | 6:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cybin Inc. (CYBN) might experience a positive impact as the FDA considers MDMA therapy approval, supported by prominent researchers.
Cybin Inc. is also involved in psychedelic therapies, and the FDA's potential approval of MDMA therapy could positively influence the stock.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Bright Minds Biosciences (DRUG) may see a positive impact as researchers advocate for FDA approval of MDMA therapy for PTSD.
Bright Minds Biosciences is involved in psychedelic research, and the positive sentiment from researchers could enhance investor confidence.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Enveric Biosciences (ENVB) might see a positive impact as the FDA considers MDMA therapy approval, supported by prominent researchers.
Enveric Biosciences is involved in psychedelic therapies, and the FDA's potential approval of MDMA therapy could positively influence the stock.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Mind Medicine (MNMD) could see positive momentum as researchers push for FDA approval of MDMA therapy for PTSD, highlighting its safety and efficacy.
Mind Medicine is involved in psychedelic therapies, and the positive sentiment from researchers could boost investor confidence in the company's prospects.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Seelos Therapeutics (SEEL) could benefit from the positive sentiment as researchers push for FDA approval of MDMA therapy for PTSD.
Seelos Therapeutics is involved in mental health therapies, and the positive sentiment from researchers could boost investor confidence.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60